Introduction. The number of clinical trials investigating the optimal timing of prophylactic antibiotics in cesarean section has increased rapidly over the last few years. We conducted a systematic review to inform up-to-date evidencebased guidelines to prevent postpartum infectious morbidity in the mother and rule out any safety issues related to antepartum antibiotic exposure in infants. Material and methods. Four bibliographic databases were searched for published reports of trials. Ongoing or unpublished studies were searched in Clinicaltrials.gov and the World Health Organization registry platform. Randomized controlled trials comparing antibiotic prophylaxis before and after cord clamping in cesarean section were eligible. Maternal and neonatal outcomes were assessed, and certainty of evidence graded. Results. In total, 18 randomized controlled trials met the inclusion criteria. Those women who received antibiotics preoperatively were 28% (relative risk 0.72, 95% confidence interval 0.56-0.92, nine studies, 4342 women, high quality of evidence) less likely to show infectious morbidity as compared with those who received antibiotics after cord clamping. The risk of endomyometritis and/or endometritis was reduced by 43% (relative risk 0.57, 95% confidence interval 0.40-0.82, 13 studies, 6250 women, high quality of evidence) and the risk of wound infection by 38% (relative risk 0.62, 95% confidence interval 0.47-0.81, 14 studies, 6450 women, high quality of evidence) in those who received antibiotics preoperatively as compared to those who received antibiotics after cord clamping. For other maternal infections no significant differences were identified. The risk for neonatal outcomes, such as deaths attributed to infection, sepsis, neonatal antibiotic treatment, intensive care unit admission or antibiotic-related adverse events, was not found to be different, either clinically or statistically, when antibiotics were given before or after cord clamping (moderate to low quality of evidence). Conclusions. The evidence in favor of prophylactic antibiotic administration before, in comparison with after, cord clamping for major maternal infections was of high quality, meaning that further research would be unlikely to change the confidence in these findings. However, we recommend additional research reflecting the precision of the effect estimates for neonatal outcomes.
Introduction
Cesarean section is one of the most common operative procedures in the world. An investigation of data from 150 countries revealed that nearly 20% of all newborns are delivered by cesarean section. Latin America and the Carribean region shows the highest rates (40.5%), the rate in Europe is approximately 25%, whereas the rate in Africa lies under 10% (1) . Compared with vaginal birth, cesarean delivery is associated with an almost fivefold increased risk of major infections (2) . Therefore, antibiotic prophylaxis is recommended for abdominal gynecologic surgery including cesarean sections (3) (4) (5) . A Cochrane review from 2014 compared antibiotic prophylaxis with no prophylaxis and concluded that antibiotic prophylaxis decreased the risk for postpartal wound infection, endometritis and severe infectious complications by 60-70% (6) . However, antibiotics can potentially be transferred to the neonate. Therefore, prophylactic antibiotics have been withheld until after neonatal umbilical cord clamping during cesarean delivery in many instances for a long period of time. For example, a guideline of the Center for Disease Control and Prevention in Atlanta (USA) from 1999 suggested antibiotic administration after cord clamping only in high risk cesarean sections (7) .
From 2008, different guidelines and reviews suggested that prophylactic antibiotics should be given before cord clamping to prevent or reduce the risk of maternal infections after the surgical procedure (4, (8) (9) (10) (11) (12) (13) (14) . Most of these existing reviews have, however, some methodological flaws, for example not using rigorous methodology, as described in the Cochrane Handbook (15) , and findings were not reported using the preferred reporting items for systematic reviews and metaanalyses (PRISMA) statement (16) . We identified one Cochrane review (8) , but this review was published 3 years ago and does not fully cover the rapidly rising number of controlled clinical trials (13, (17) (18) (19) (20) (21) (22) (23) investigating the optimal timing of prophylactic antibiotics. Given the widespread prophylactic use of antibiotics before cord clamping and the emerging evidence comparing prophylactic antibiotics before and after cord clamping in cesarean section, we conducted a systematic review to inform up-to-date evidence-based guidelines to prevent postpartum infectious morbidity in the mother and rule out any safety issues related to antepartum antibiotic exposure in infants.
Material and methods
We followed the reporting guidelines provided by the PRISMA statement (16) .
Published studies were identified from searches of electronic databases. We searched Medline (via Ovid), Embase (via Ovid), Web of Science (via Thomson Reuters) and the Cochrane Central Register of Controlled Trials (via www.cochranelibrary.com) from inception until May 2016. An update search was performed in March 2017. The search strategy was based on combinations of medical subject headings (MeSH) and key words and was not restricted to any specific languages. The search strategy used in Medline (Ovid) is presented in Figure S1 . Search strategies for other databases were modified to meet the requirements of each database. Additionally, reference lists of all included clinical studies and identified systematic reviews were screened for further trials. Ongoing and unpublished studies were identified by searching the Register for Clinical Trials (http://clinicaltri als.gov/) and the World Health Organization International Clinical Trials Registry Platform (http://www.who. int/ictrp/en/). One reviewer (C.B.) screened the titles and abstracts of all reports identified by electronic searches. We obtained full-text copies of all potentially relevant articles, and two reviewers (C.B., C.S.) independently assessed them for inclusion.
We included randomized controlled trials (RCTs) comparing prophylactic antibiotic administration before umbilical cord clamping with administration after cord clamping in cesarean delivery. Eligible women were individuals with cesarean section of any type, irrespective of age, comorbidity or antibiotic agent. We did not consider study results solely reported in abstract form. The reason for not including abstracts was that this publication type does not allow a thorough risk of bias assessment due to lack of detailed information about trial methods.
Relevant study data were extracted on: (i) population: indication of cesarean section, number of randomized women, number of women randomized to administration before and after cord clamping, duration of follow up;
(ii) interventions: antibiotic classes and agents, dosing, administration route, timing; (iii) maternal outcomes: composite infectious morbidity as defined by the authors of the clinical trial, endometritis and/or endomyometritis, wound infection, urinary tract infection (UTI), cystitis, pyelonephritis, respiratory tract infection, pneumonia, fever, hospital length of stay, adverse events attributed to the antibiotic, mortality and other outcomes reported in the trials; (iv) neonatal outcomes: mortality, sepsis, sepsis workup (diagnostic of suspected sepsis), intensive care unit (ICU) admission, risk of allergy or atopy and any other outcomes reported in the trials. We collected outcomes at the maximum follow-up times reported.
Risk of bias for the included studies was assessed according to the methodology described in the Cochrane Handbook for Systematic Reviews of Interventions (15) . The following key domains were covered: (i) randomization sequence generation, (ii) allocation concealment, (iii) masking (blinding) of participants, trial personal, and outcome assessors in terms of the timing of the antibiotic prophylaxis, (iv) incomplete outcome data, (v) selective outcome reporting (for example, absence of data for outcomes measured), and (vi) other sources of bias (for example, bias due to problems not covered elsewhere). The quality of evidence for prespecified outcomes taking into account risk of bias, inconsistency, indirectness and imprecision was assessed using the grading of recommendations, assessment, development and evaluation (GRADE) approach (24) .
The reviewers mentioned above also independently carried out data extraction, risk of bias assessment and the GRADE assessment. Disagreements were resolved by discussion and consensus.
Primary meta-analyses were conducted using Review Manager (REVMAN) Version 5.3 (25) . For binary outcomes, we calculated relative risks (RR) and their 95% confidence intervals (95% CI). For continuous outcomes, we calculated mean differences and their 95% CI. The calculations were based on a random-effects model. Additionally, random-effects logistic regressions using R were performed (26) . Effect estimates were expressed as odds ratios using the single study as cluster unit for all binary outcomes reporting at least one event in one of the study arms. The results of these analyses -which showed no remarkable differences to the primary random-effects model meta-analyses -are shown in Figure S2 . Subgroup analyses were performed to examine whether estimates of RR were affected by the indication of cesarean section (elective vs. non-elective), dose of cephalosporin (1 g once vs. 2 g once), time interval between administration of antibiotics and surgery (>30 min vs. ≤30 min prior to skin incision), and countries with different healthcare assistance (high-vs. low-and middle-income countries).
Subgroup differences were assessed by interaction tests available within REVMAN Version 5.3 (25) . We calculated the I 2 statistic for all meta-analyses. The I 2 test describes the percentage of total variation across studies that is attributable to heterogeneity rather than chance (27) .
This project was initiated by the German Society for Gynecology and Obstetrics to answer a clinical question for the multidisciplinary expert group of the German evidence-and consensus-based guideline project "Sectio Cesarea" and was supported by the German Federal Ministry of Health (#GE 20160425). The awarded grant did not include an external peer review for scientific quality or priority assessment. The funder had no input in the design, conduct, analysis or interpretation of the data, or in the preparation, review, or approval of the manuscript.
Results
After elimination of duplicates between databases, we identified 7098 titles and abstracts; for 393 of these, the full text was evaluated ( Figure 1 ). We included 18 RCTs comparing the application of prophylactic antibiotics before vs. after cord clamping (13, (17) (18) (19) (20) (21) (22) (23) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) . The studies were conducted in the USA (17, 20, 29, (32) (33) (34) (35) , Turkey (37), Austria (36), India (28, 30) , Iran (18, 21) , Egypt (31), Tunisia (19) , Sudan (22) , Italy (23) and China (13) . The indication for the cesarean section, number of randomized women in treatment groups, antibiotic class, agent and dosing scheme of the administered antibiotic(s) and the actual time when the antibiotic(s) were given, are presented in Table S1 . In brief, 13 studies included women with elective cesarean section solely (13, (17) (18) (19) (20) 22, (29) (30) (31) (32) (33) 36, 37) , two studies reported that more than 75% of women received elective cesarean section (21, 28) , and three studies were focused on non-elective cesarean section (23, 34, 35) . The majority of studies administered a first-generation cephalosporin (cefazolin 1 g, cefazolin 2 g or cefathiamidin 2 g) (13, 18, 19, 21, 29, (31) (32) (33) (34) (35) (36) (37) . One study investigated a combination of two antibiotics (20) . The longest follow up reported was six weeks. However, in most of the studies, followup did not exceed the length of the stay in hospital.
Maternal outcomes
Maternal outcomes were investigated in 15 studies including 6841 women (18) (19) (20) 22, 23, (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) . There were significant reductions in composite infectious morbidity (as defined by study authors) for women who received antibiotics preoperatively as compared with those who received antibiotics after cord clamping (RR 0.72, 95% CI 0.56-0.92, nine studies, 4342 women, high quality of evidence) ( Figure 2a , Table 1 ). In other words, women who received antibiotics preoperatively were between 8 and 44% less likely to show composite infectious morbidities as compared with those who received antibiotics after neonatal cord clamping. There was little evidence of between trial heterogeneity (I 2 = 7%). The risk of endomyometritis and/or endometritis was reduced by 43% (RR 0.57, 95% CI 0.40-0.82, 13 studies, 6250 women, high quality of evidence) and the risk of wound infection by 38% (RR 0.62, 95% CI 0.47-0.81, 14 studies, 6450 women, high quality of evidence) in those who received antibiotics preoperatively as compared with those who received antibiotics after cord clamping (Figure 2b ,f, respectively, Table 1 ). Although a significant difference was noted in the hospital length of stay favoring preoperative antibiotics, the difference of 0.13 days (95% CI À0.25 to À0.01, three studies, 2083 women, high quality of evidence) is unlikely to be clinically relevant (Figure 2h , Table 1 ).
There were no significant differences in occurrence of UTI/cystitis/pyelonephritis (RR 1.01, 95% CI 0.64-1.59, nine studies, 4088 women, moderate quality of evidence) ( Figure 2c , Table 1 Table 1 ).
Maternal death (874 women) (30) and infections caused by methicillin-resistant Staphylococcus aureus (MRSA) (741 women) (36) , bacteremia (874 women) (30), intra-abdominal abscess (90 women) (35) and necrotizing fasciitis (874 women) (30) were evaluated in one study, respectively. Sepsis including septic shock (1615 women) (30, 36) was evaluated in two and septic (pelvic) thrombophlebitis (1353 women) (30, 35, 37) in three studies. However, none of these studies reported any events, so RR could not be calculated (results not shown in a graph). Quality of evidence for these outcomes was low due to zero events in studies and small study size (Table 1) . Table S2 presents results from stratified analyses for composite infectious morbidity (as defined by study authors), endometritis and/or endomyometritis, UTI, respiratory tract infections, fever, wound infection and hospital length of stay. Estimates of RR varied slightly Outcome not relevant n = 2
Study type not relevant n = 97
Full-text articles assessed for eligibility
Studies included in qualitative synthesis
Studies included in quantitative synthesis (meta-analysis) depending on whether women with elective cesarean section had been compared with those with non-elective cesarean section, but 95% CIs overlapped and a test of interaction was not significant (p > 0.61 applies to all outcomes). Similarly, there was no evidence that RRs differed depending on the dose of cephalosporin, the time when antibiotics were given or the country where the study was conducted.
Neonatal outcomes
Neonatal outcomes were reported in 13 studies (13, 17, 19, 21, 22, (28) (29) (30) (32) (33) (34) (35) 37) . There were no significant differences in risk for sepsis (RR 0.77, 95% CI 0.52-1.13, eight studies, 3690 newborns, moderate quality of evidence) ( Figure 3a , Table 2 ), sepsis workup (RR 0.90, 95% CI 0.70-1.17, seven studies, 2069 newborns, moderate quality of evidence) ( Figure 3b , Table 2 ), infection with an antibiotic-resistant bacterium (RR 0.70, 95% CI 0.12-4.14; two studies, 813 newborns, low quality of evidence) ( Figure 3c , Table 2 ), neonatal antibiotic treatment (RR 0.68, 95% CI 0.21-2.16, two studies, 872 newborns, moderate quality of evidence) ( Figure 3d , Table 2 ), fever (RR 0.67, 95% CI 0.28-1.62, one study, 953 newborns, low quality of evidence) ( Figure 3e , Table 2 ) and ICU admission (RR 0.89, 95% CI 0.74-1.08, 11 studies, 5294 newborns, moderate quality of evidence) ( Figure 3f , Table 2 ).
There was also no significant difference in the length of ICU stay (mean difference À1.33, 95% CI À5.32 to 2.66, three studies, 1731 newborns, low quality of evidence) ( Figure 3g , Table 2 ). Moreover, no adverse events (one study, 886 newborns, low quality of evidence) (30) or neonatal death attributed to infection (one study, 886 newborns, low quality of evidence) (30) were observed (results not shown in a graph, Table 2 ). Table S3 presents results from stratified analyses for the outcomes neonatal sepsis, suspected sepsis (sepsis workup), neonatal antibiotic treatment, ICU admission and length of ICU stay. Although a significant difference was noted in the neonatal length of ICU stay when countries with different healthcare assistance were compared, this difference in favor of preoperative antibiotics in high-income countries is unlikely to be attributed to the country where the study was performed. This difference may rather be explained by chance because only one study conducted in high-income countries contributed to the subgroup analysis (33) . Otherwise there was no evidence that RRs differed depending on the indication for cesarean section, dose of cephalosporin, the time when antibiotics were given or the country where the study was conducted (p > 0.12 applies to all outcomes).
Risk of bias
The risk of bias summary for each study is presented in Figure 4 . The studies mostly reported sufficient details An additional study (Kalaranjini 2013 ) reported the length of hospital stay. The length of hospital stay was not different between both groups (5.6 days). It was not possible to calculate the standard deviation from given information, so the study could not be considered for meta-analysis.
about random sequence generation and allocation concealment (13, 22, (28) (29) (30) (31) 33, (35) (36) (37) . Adequate blinding of study participants and personal and/or outcome assessor was reported in 12 trials. The remaining trials were either open label (20) or the available information did not allow a judgement about whether the women and study personal were aware of the time point of the antibiotic given (18, 23, 30, 31, 37) . One study showed an unclear risk of bias concerning missing outcome data (35) . Selective reporting could not be assessed in the majority of studies due to missing information, i.e. no protocol was prepublished. No other sources of bias were identified in the included trials.
Discussion
Our aggregated evidence shows that women who received antibiotics preoperatively were 28% less likely to develop composite infectious morbidities as compared with those who received antibiotics after neonatal cord clamping. The risk of maternal endomyometritis and/or endometritis was reduced by 43% and the risk of wound infection by 38% in those who received antibiotics preoperatively as compared with those who received antibiotics after cord clamping. Although a significant difference was noted in the hospital length of stay favoring preoperative antibiotics, the difference of 0.13 days is unlikely to be clinically relevant. For other maternal infections such as sepsis, UTI including cystitis and pyelonephritis, infections of the respiratory tract including pneumonia‚ infections caused by MRSA, necrotizing fasciitis, fever or pelvic abscess, no difference regardless of when the antibiotics were administered were found. No maternal deaths were noted in any of the studies. The risk for neonatal outcomes, such as deaths attributed to infections, sepsis, fever, neonatal antibiotic treatment, ICU admission, ICU length of stay or antibiotic-related adverse events, was neither clinically nor statistically increased when antibiotic prophylaxis was given before cord clamping. Existing concerns for delayed diagnosis of neonatal infection (sepsis workup) (38) , neonatal antibiotic resistance, an increased risk for allergies and disorders of the neonatal gut flora (13) were not supported by the available evidence from randomized studies.
Prophylactic antibiotic treatment was given between 15 and 60 min before skin incision in most studies. This varying time frame did not allow us to judge whether there is a specific time preoperatively that resulted in the best possible risk reduction. Another debate related to cesarean delivery is the choice of antibiotics (39) . In all but one study (17) , first-generation or third-generation cephalosporins were the first choice of antibiotic prophylaxis in cesarean delivery. There was no heterogeneity observed throughout our meta-analyses, suggesting that narrow-range antibiotic prophylaxis (first-generation cephalosporins) may be equal to broad-spectrum antibiotic prophylaxis such as ceftriaxone, ceftizoxim and ceftazidime. 
⨁⨁◯◯ LOW
Setting: Hospitals in China (one study), India (two studies), Iran (one study), Sudan (one study), Turkey (one study), Tunisia (one study), USA (six studies).
CI, confidence interval; MD: mean difference; RR, risk ratio.
a Due to 0 events in both groups, the overall effect was not calculable.
b Very serious imprecision due to no events in both groups and low number of included women. An additional study (Witt 2011) reported that no oral thrush or other potential adverse events attributed to antibiotic appeared during the study in the newborns, but the number of included newborns was not given. This systematic review is based on evidence of 18 RCTs including nearly 8000 women and over 5000 neonates. Maternal outcomes were reported in 15 and neonatal outcomes in 13 studies. The RCTs were published between 1979 (17) and 2016 (19) in 10 countries: two studies in Europe included 941 women, seven studies in the USA included 2557 women and the remaining studies in the Middle East, China and India included 4237 women. Despite different hygienic standards and spectrum of pathogens that may be present in both low-and high-income countries and considering the extending study period of more than 35 years, the results were generally consistent across the trials, suggesting high applicability of the evidence worldwide.
We used the GRADE approach to assess the quality of the evidence. We judged the evidence for prophylactic antibiotic administration before compared with after neonatal cord clamping for maternal composite infectious morbidity, endomyometritis/endometritis and wound infection to be of high quality, meaning that we are very confident that the true effect lies close to that of the estimate of the effect and further research would be very unlikely to change our confidence in the result or the size of the estimate of the effect. For maternal UTI and fever, which showed no difference regardless of when the antibiotics were administered, the evidence using GRADE was downgraded to moderate quality (due to imprecision), meaning that we are moderately confident that the true effect lies close to that of the estimate of the effect and further research would be likely to change our confidence or the size of the effect estimate. The quality of evidence was low for all other maternal outcomes, including infections of the respiratory tract and antibiotic-related adverse events, meaning that our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect and further research would be very likely to change our confidence and the size of the effect estimate. Downgrading was due the low number of women in these studies, few events and very wide 95% confidence intervals, that include both appreciable benefit and appreciable harm.
The quality for the evidence for neonatal outcomes including sepsis, sepsis workup, neonatal antibiotic treatment and ICU admission was rated as moderate, and for outcomes including infections with resistant organism, fever and ICU length of stay the evidence quality was low. Again, the moderate quality of evidence for neonatal outcomes can be explained by imprecision and the low quality of evidence was either due to very wide confidence intervals or serious inconsistencies.
For outcomes including maternal and neonatal death attributed to infections, maternal sepsis, maternal infections caused by MRSA and neonatal antibiotic-related adverse events, effect estimates could not be calculated due to zero events in both study arms. There were nine systematic reviews (8) (9) (10) (11) (12) (13) (14) 40, 41) and three guidelines, one from the National Institute for Health and Clinical Excellence (NICE) (4), one from the American College of Obstetricians and Gynecologists (ACOG) (3) and another one from the Society of Obstetricians and Gynaecologists of Canada (SOGC) (5) , that examined maternal and neonatal infectious morbidity in women undergoing cesarean delivery receiving preoperative antibiotic prophylaxis compared with those receiving postoperative antibiotics. These reviews and guidelines were published between 2008 (14) and 2015 (13) and included between three (14) and 10 (8) randomized studies. In contrast, our systematic review included 18 RCTs.
Most reviews or guidelines recommend antibiotic prophylaxis prior to skin incision in cesarean delivery (3) (4) (5) (8) (9) (10) (11) (12) 14, 40, 41) . These recommendations are mainly based on the findings that preoperative administration of antibiotics leads to a significant decrease in endomyometritis and/or endometritis (between 41 and 53%) (4, (8) (9) (10) (11) (12) 14) and maternal infectious morbidity (between 29 and 50%) (4, (8) (9) (10) 14) . One meta-analysis, which was based solely on elective cesarean delivery, did not find a risk reduction for any maternal outcome in favor of preoperative in comparison with postoperative antibiotic prophylaxis (13) . The authors of that review claimed that their inconsistency could be explained by the fact that other reviews did not distinguish between elective and emergency cesarean section. However, our stratified analyses provided no evidence that RRs differed depending on the indication for cesarean section.
The risk for wound infection in favor of the preoperative administration was also reduced in a Cochrane review published in 2014 (8) . Other reviews suggested such an effect, but no statistical difference in favor of antibiotics before, in comparison with after, umbilical cord clamping was observed (4, (9) (10) (11) (12) (13) (14) . It is most likely that the more precise and statistically significant estimate of the pooled risk ratio in our review is the result of a larger number of identified studies (leading to more participants and events) in comparison with other reviews.
Reviews investigating the risk of fever (4, 8, 9) , UTI (4,8,9,11-13) or infections of the respiratory tract (4, 8, 9) did not find a statistically significant difference between the different application time points -identical with our finding.
None of the other reviews or guidelines identified disadvantages for the neonates when the prophylaxis is given before cord clamping. However, it was striking that specific outcomes such as neonatal infectious mortality, antibiotic-related adverse events, UTI or pneumonia have not been evaluated in systematic reviews or guidelines before. The same is true for maternal outcomes such as infectious mortality, sepsis, infection caused by MRSA, and antibiotic-related adverse events.
Conclusion
This systematic review is based on 18 RCTs including nearly 8000 women and over 5000 neonates from 10 countries. The evidence for prophylactic antibiotic administration before, in comparison with after, neonatal cord clamping for maternal composite infectious morbidity, endomyometritis/endometritis and wound infection was judged to be of high quality, meaning that further research would be very unlikely to change our confidence in the result or the size of the estimate of the effect. The evidence for the hospital length of stay for the mother was also of high quality. However, the clinical relevance of 0.13 days is questionable. Other maternal outcomes showed no difference regardless of when the antibiotic was administered. Quality of evidence for these outcomes was moderate to low. The results were generally consistent across the trials, suggesting high applicability of the evidence for a wide range of women with different indications for cesarean section. Similarly, there was no evidence that RRs differed depending on the dose of cephalosporin, the time when antibiotics were given or the country where the study was conducted.
There was moderate quality of evidence according to GRADE that prophylactic antibiotic administration before, in comparison with after, cord clamping yields no difference in neonatal sepsis, sepsis workup, the need for antibiotic treatment or ICU admission. For neonatal death attributed to infection, antibiotic-related adverse events, infections with a resistant organism, fever and ICU length of stay, which also showed no difference regardless of when the antibiotics were administered, the quality of evidence was low. The major uncertainty for neonatal outcomes was the size of the effect estimate. Additional research reflecting the precision of the effect size estimates in neonatal outcomes are needed to rule out definitively any safety issues related to antepartum antibiotic exposure in infants.
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